Moreover , patients included in the treatment group had a clinically significant reduction of PVR ( 46.1 vs. 25.2 mL ; P = 0.1 ) and a slight increase in Qmed ( 5.6 vs. 6.5 mL/s ; P = 0.9 ) after three months of chronic treatment with Difaprost .